Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Travel and the immunocompromised host.

C P Conlon1

  • 1Nuffield Department of Medicine, John Radcliffe Hospital, Oxford.

Hospital Medicine (London, England : 1998)
|May 2, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Whole-genome sequencing identifies nosocomial transmission of extra-pulmonary M. tuberculosis-response.

QJM : monthly journal of the Association of Physicians·2017
Same author

Whole-genome sequencing identifies nosocomial transmission of extra-pulmonary M. tuberculosis.

QJM : monthly journal of the Association of Physicians·2016
Same author

Elevation of the JVP in constrictive pericarditis.

QJM : monthly journal of the Association of Physicians·2015
Same author

A constricting differential--a case of severe anaemia, weight loss and pericarditis due to Tropheryma whipplei infection.

QJM : monthly journal of the Association of Physicians·2012
Same author

Fevers, headache and abnormal liver function in a 68-year-old man.

Journal of the Royal Society of Medicine·2010
Same author

A case of empyema necessitatis.

European journal of internal medicine·2007

Immunocompromised patients face increased travel risks due to global access and medical progress. This article offers guidance on travel health advice and vaccine limitations for these vulnerable individuals.

Area of Science:

  • Travel Medicine
  • Infectious Diseases
  • Immunocompromised Hosts

Background:

  • Advances in medicine and increased travel opportunities allow immunocompromised patients to visit diverse global destinations.
  • These patients are at a higher risk of contracting infections in regions with prevalent endemic diseases.
  • Standard travel health recommendations may not fully address the unique needs of immunocompromised travelers.

Purpose of the Study:

  • To examine the specific health risks encountered by immunocompromised individuals during international travel.
  • To discuss the limitations of conventional travel vaccines in protecting this patient group.
  • To provide evidence-based recommendations for advising immunocompromised travelers on risk mitigation.

Main Methods:

  • Literature review of infectious disease risks in common travel destinations.

Related Experiment Videos

  • Analysis of vaccine efficacy and safety data for immunocompromised populations.
  • Synthesis of current guidelines and expert opinion on travel health for immunocompromised patients.

    • Main Results:

    • Identified key infectious disease threats relevant to immunocompromised travelers, including zoonotic and vector-borne illnesses.
    • Highlighted that standard travel vaccines may offer suboptimal protection or pose safety concerns for certain immunocompromised individuals.
    • Emphasized the need for personalized risk assessment and tailored prophylactic strategies.

    Conclusions:

    • Immunocompromised patients require specialized pre-travel consultations to address unique health risks.
    • Vaccine selection and chemoprophylaxis must be individualized based on the patient's immune status and travel itinerary.
    • Proactive risk management is crucial to ensure the safety of immunocompromised individuals undertaking international travel.